Molecular epidemiology of non-small cell lung cancer

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 3, 2005, Pages 265-272

  Liu, Geoffrey ^a,b,c   Zhou, Wei ^c   Christiani, David C ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic susceptibility; Lung cancer; Molecular epidemiology; Polymorphism

Indexed keywords

CARCINOGEN; GLUTATHIONE TRANSFERASE; PROTEIN P53;

CANCER RISK; CANCER SUSCEPTIBILITY; CYP GENE; DNA POLYMORPHISM; DNA REPAIR; EXCISION REPAIR; GENE; GENETIC PREDISPOSITION; HUMAN; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MGMT GENE; NAT GENE; PRIORITY JOURNAL; REVIEW; SMOKING; TOBACCO; TUMOR SUPPRESSOR GENE; XENOBIOTIC METABOLISM; XPD GENE; XRCC1 GENE;

CARCINOMA, NON-SMALL-CELL LUNG; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 22144494663     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-871983     Document Type: Review

References (65)

1. American Cancer Society. Tobacco use. In: American Cancer Society, ed. Cancer Facts & Figures 2001. Atlanta, GA: American Cancer Society; 2001:29-32
2. Smith-Warner SA, Spiegelman D, Yaun SS, et al. Fruits, vegetables and lung cancer: a pooled analysis of cohort studies. Int J Cancer 2003;107:1001-1011
3. Fabricius P, Lange P. Diet and lung cancer. Monaldi Arch Chest Dis 2004;59:207-211
4. Miller AB, Altenburg HP, Bueno-de-Mesquita B, et al. Fruits and vegetables and lung cancer: findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2004;108:269-276
5. Christiani DC. Utilization of biomarker data for clinical and environmental intervention. Environ Health Perspect 1996; 104(Suppl 5):921-925
6. Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene 2004;23:6500-6523
7. Rottman H. Uber primare Lungencarcinoma. Inaugural dissertation. Universitat Wurzburg, 1898
8. Adler I. Primary Malignant Growths of the Lung and Bronchi. London: Longmans Green & Co; 1912
9. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma. JAMA 1950;143: 329-336
10. Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. BMJ 1950;2:739-748
11. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General, http://www.hhs.gov/surgeongeneral/ library/smokingconsequences/
12. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-1210
13. Miller CW, Simon K, Aslo A, et al. p53 mutations in human lung tumors. Cancer Res 1992;52:1695-1698
14. Law MR. Genetic predisposition to lung cancer. Br J Cancer 1990;61:195-206
15. Hoffmann D, Hecht SS. Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions. Cancer Res 1985;45:935-944
16. Lambert WC, Kuo HR, Lambert MW. Xeroderma pigmentosum. Dermatol Clin 1995;13:169-209
17. Kuper H, Adami HO, Boffetta P. Tobacco use, cancer causation and public health impact. J Intern Med 2002;251: 455-466
18. Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans. J Natl Cancer Inst 1963;30:289-312
19. Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for lung cancer. J Natl Cancer Inst 1986;76:217-222
20. Sellers TA, Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H. Increased familial risk for non-lung cancer among relatives of lung cancer patients. Am J Epidemiol 1987;126:237-246
21. Sellers TA, Elston RC, Stewart C, Rothschild H. Familial risk of cancer among randomly selected cancer probands. Genet Epidemiol 1988;5:381-391
22. Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA. Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 1991;44:429-437
23. Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823
24. Sellers TA, Bailey-Wilson JE, Elston RC, et al. Evidence for mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst 1990;82:1272-1279
25. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 1996;144:554-562
26. Mayne ST, Buenconsejo J, Janerich DT. Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidemiol Biomarkers Prev 1999; 8:1065-1069
27. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460-474
28. Thorisson GA, Stein LD. The SNP Consortium website: past, present and future. Nucleic Acids Res 2003;31:124-127
29. Benhamou S, Lee WJ, Alexandrie AK, et al. Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis 2002;23:1343-1350
30. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5325
31. Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5325
32. Yagil Y, Yagil C. Candidate genes, association studies and haplotype analysis in the search for the genetic basis of hypertension. J Hypertens 2004;22:1255-1258
33. Wiencke JK, Kelsey KT, Varkonyi A, et al. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res 1995;55:4910-4914
34. Wogan GN, Gorelick NJ. Chemical and biochemical dosimetry of exposure to genotoxic chemicals. Environ Health Perspect 1985;62:5-18
35. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 2000;9: 3-28
36. Reszka E, Wasowicz W. Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk. Int J Occup Med Environ Health 2001;14: 99-113
37. Gelboin HV. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol Rev 1980;60:1107-1166
38. Hein DW, Doll MA, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res 1995; 55:3531-3536
39. Lee WJ, Brennan P, Boffetta P, et al. Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers 2002;7:230-241
40. Williams JA. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: why molecular epidemiologists should think about enzyme expression. Carcinogenesis 2001;22:209-214
41. Kiyohara C, Otsu A, Shirakawa T, Fukuda S, Hopkin JM. Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 2002;37:241-256
42. Williams MD, Sandler AB. The epidemiology of lung cancer. Cancer Treat Res 2001;105:31-52
43. Hirvonen A. Polymorphic NATs and cancer predisposition. IARC Sci Publ 1999;148:251-270
44. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003;18:377-385
45. Feyler A, Voho A, Bouchardy C, et al. Point: myeloperoxidase-463G: a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1550-1554
46. Zhou W, Liu G, Thurston SW, et al. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:15-21
47. Berwick M, Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 2000;92:874-897
48. Wei Q, Cheng L, Amos CI, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 2000;92: 1764-1772
49. Duell EJ, Wiencke JK, Cheng TJ, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000;21:965-971
50. Ratnasinghe D, Yao SX, Tangrea JA, et al. Polymorphisms of the DNA repair gene XRCC1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:119-123
51. Chen S, Tang D, Xue K, et al. DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 2002;23:1321-1325
52. Park JY, Lee SY, Jeon HS, et al. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:23-27
53. David-Beabes GL, London SJ. Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer 2001;34:333-339
54. Misra RR, Ratnasinghe D, Tangrea JA, et al. Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett 2003;191:171-178
55. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005;97:567-576
56. Zhou W, Liu G, Miller DP, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:359-365
57. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol 2005; 161:1-14
58. Johnson ES. Nested case-control study of lung cancer in the meat industry. J Natl Cancer Inst 1991;83:1337-1339
59. Zhou W, Liu G, Park S, et al. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2005;14:491-496
60. Wu X, Zhao H, Wei Q, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003;24: 505-509
61. Butkiewicz D, Popanda O, Risch A, et al. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Cancer Epidemiol Biomarkers Prev 2004;13:2242-2246
62. Park JY, Park SH, Choi JE, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002;11:993-997
63. Kaur TB, Travaline JM, Gaughan JP, et al. Role of polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002;9:339-342
64. Cohet C, Borel S, Nyberg F, et al. Exon 5 polymorphisms in the O6-alkylguanine DNA alkyltransferase gene and lung cancer risk in nonsmokers exposed to secondhand smoke. Cancer Epidemiol Biomarkers Prev 2004;13:320-323
65. Krzesniak M, Butkiewicz D, Samojedny A, Chorazy M, Rusin M. Polymorphisms in TDG and MGMT genes: epidemiological and functional study in lung cancer patients from Poland. Ann Hum Genet 2004;68:300-312